{"id":3206,"date":"2021-09-20T16:36:16","date_gmt":"2021-09-20T20:36:16","guid":{"rendered":"https:\/\/www.med.unc.edu\/obgyn\/horizons\/?p=3206"},"modified":"2021-09-20T16:36:16","modified_gmt":"2021-09-20T20:36:16","slug":"infographic-buprenorphine-naloxone-as-a-medication-to-treat-opioid-use-disorder-among-pregnant-women","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/obgyn\/horizons\/infographic-buprenorphine-naloxone-as-a-medication-to-treat-opioid-use-disorder-among-pregnant-women\/","title":{"rendered":"INFOGRAPHIC: Buprenorphine-Naloxone as a Medication to Treat Opioid Use Disorder Among Pregnant Women"},"content":{"rendered":"

\"Photo
\nBuprenorphine-Naloxone as a Medication to Treat Opioid Use Disorder Among Pregnant Women<\/strong>
\nResearch reaffirms the efficacy, safety, and access of buprenorphine-naloxone as a medication to treat opioid use disorder (MOUD) among women in pregnancy.<\/p>\n

 <\/p>\n

What The Data Says<\/strong><\/p>\n

\u2022 Findings from a systemic review, meta-analysis, and subgroup analysis reinforce previous support indicating buprenorphine-naloxone during pregnancy has similar pregnancy and neonatal outcomes compared to other forms of treatment such as buprenorphine alone or methadone.<\/p>\n

\u2022 Results from a subgroup analysis reaffirm that buprenorphine-naloxone treatment has a decreased potential for misuse when compared with that of buprenorphine alone, and in some cases is more available than other forms of treatment.<\/p>\n

 <\/p>\n

What Does This Mean?<\/strong><\/p>\n

\u2022Pregnant patients with opioid use disorder and their clinical care team can be reassured that taking buprenorphine-naloxone is relatively safe and effective for both parent and child .<\/p>\n

 <\/p>\n

CLICK BELOW TO VIEW INFOGRAPHIC:<\/p>\n

INFOGRAPHIC: Buprenorphine-Naloxone as a Medication to Treat Opioid Use Disorder Among Pregnant Women<\/a><\/p>\n

Link, Heather Met al. “Buprenorphine-naloxone use in pregnancy: a subgroup analysis of medication to treat opioid use disorder.” American journal of obstetrics & gynecology MFM, vol. 3,5100369. 5 Apr. 2021, doi:10.1016\/j.ajogmf.2021.100369 Link, Heather Met al. “Buprenorphine-naloxone use in pregnancy: a systematic review and metaanalysis.” American journal of obstetrics & gynecology MFM vol. 2,3 (2020): 100179. doi:10.1016\/j.ajogmf.2020.100179<\/p>\n","protected":false},"excerpt":{"rendered":"

Buprenorphine-Naloxone as a Medication to Treat Opioid Use Disorder Among Pregnant Women Research reaffirms the efficacy, safety, and access of buprenorphine-naloxone as a medication to treat opioid use disorder (MOUD) among women in pregnancy.   What The Data Says \u2022 Findings from a systemic review, meta-analysis, and subgroup analysis reinforce previous support indicating buprenorphine-naloxone during … Read more<\/a><\/p>\n","protected":false},"author":38652,"featured_media":3214,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[2],"tags":[],"class_list":["post-3206","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","odd"],"acf":[],"featured_image":"https:\/\/www.med.unc.edu\/obgyn\/horizons\/wp-content\/uploads\/sites\/790\/2021\/09\/Bupe-Nalaxone-Infographic-9.17.21.jpg","featured_image_medium":"https:\/\/www.med.unc.edu\/obgyn\/horizons\/wp-content\/uploads\/sites\/790\/2021\/09\/Bupe-Nalaxone-Infographic-9.17.21-206x300.jpg","featured_image_medium_large":"https:\/\/www.med.unc.edu\/obgyn\/horizons\/wp-content\/uploads\/sites\/790\/2021\/09\/Bupe-Nalaxone-Infographic-9.17.21-768x1121.jpg","featured_image_large":"https:\/\/www.med.unc.edu\/obgyn\/horizons\/wp-content\/uploads\/sites\/790\/2021\/09\/Bupe-Nalaxone-Infographic-9.17.21-701x1024.jpg","featured_image_thumbnail":"https:\/\/www.med.unc.edu\/obgyn\/horizons\/wp-content\/uploads\/sites\/790\/2021\/09\/Bupe-Nalaxone-Infographic-9.17.21-150x150.jpg","featured_image_alt":"Photo of Infographic: Buprenorphine-Naloxone Use As Opiod Treatment Among Pregnant Women","category_details":[{"name":"News","link":"https:\/\/www.med.unc.edu\/obgyn\/horizons\/category\/news\/"}],"tag_details":[],"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/obgyn\/horizons\/wp-json\/wp\/v2\/posts\/3206","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/obgyn\/horizons\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.med.unc.edu\/obgyn\/horizons\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/obgyn\/horizons\/wp-json\/wp\/v2\/users\/38652"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/obgyn\/horizons\/wp-json\/wp\/v2\/comments?post=3206"}],"version-history":[{"count":0,"href":"https:\/\/www.med.unc.edu\/obgyn\/horizons\/wp-json\/wp\/v2\/posts\/3206\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/obgyn\/horizons\/wp-json\/wp\/v2\/media\/3214"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/obgyn\/horizons\/wp-json\/wp\/v2\/media?parent=3206"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.med.unc.edu\/obgyn\/horizons\/wp-json\/wp\/v2\/categories?post=3206"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.med.unc.edu\/obgyn\/horizons\/wp-json\/wp\/v2\/tags?post=3206"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}